Clopidogrel and Weakness - a phase IV clinical study of FDA data
Summary:
Weakness is reported as a side effect among people who take Clopidogrel (clopidogrel), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Amlodipine, and have High blood pressure.
The phase IV clinical study analyzes which people have Weakness when taking Clopidogrel. It is created by eHealthMe based on reports of 91,038 people who have side effects when taking Clopidogrel from the FDA, and is updated regularly.
What is Clopidogrel?
Clopidogrel has active ingredients of clopidogrel. It is often used in blood clots. eHealthMe is studying from 92,157 Clopidogrel users. Check the latest studies of Clopidogrel.
What is Weakness?
Weakness is found to be associated with 3,639 drugs and 6,587 conditions by eHealthMe. Check the latest studies of Weakness.
91,038 people reported to have side effects when taking Clopidogrel.
Among them, 3,871 people (4.25%) have Weakness.
Among these 3,871 people:
How long have people been on Clopidogrel when they have Weakness? *
What is the gender of people who have Weakness when taking Clopidogrel? *
What is the age of people who have Weakness when taking Clopidogrel? *
What are other drugs people take besides Clopidogrel? *
What are other side effects people have besides Weakness? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Clopidogrel and have Weakness?
- Check whether Weakness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Clopidogrel:
- Clopidogrel (92,157 reports)
Weakness treatments and more:
- Weakness (586,873 reports)
How severe was Weakness and when was it recovered:
Expand to all the drugs that have ingredients of clopidogrel:
- Weakness and drugs with ingredients of clopidogrel (3,871 reports)
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Clopidogrel:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Weakness:
- Weakness (3,639 drugs)
Browse all the conditions that are associated with Weakness:
- Weakness (6,587 conditions)
Related publications that referenced our studies
- Lai SW, Lin CL, Liao KF, "Actively using clopidogrel correlates with an increased risk of acute pancreatitis in Taiwan", International journal of cardiology, 2015 Mar .
- Jacob S, Dunn BL, Qureshi ZP, Bandarenko N, Kwaan HC, Pandey DK, McKoy JM, Barnato SE, Winters JL, Cursio JF, Weiss I, "Ticlopidine-, clopidogrel-, and prasugrel-associated thrombotic thrombocytopenic purpura: a 20-year review from the Southern Network on Adverse Reactions (SONAR)", InSeminars in thrombosis and hemostasis, 2012 Jan .
- Frank P, "Ticlopidine-, Clopidogrel-, and Prasugrel-Associated Thrombotic Thrombocytopenic Purpura: A Twenty-Year Review from the Southern Network on Adverse Reactions (SONAR)", , 2012 Jan .
- Lai SW, Lin CL, Liao KF, "Actively using clopidogrel correlates with an increased risk of acute pancreatitis in Taiwan", International journal of cardiology, 2015 Mar .
- Jacob S, Dunn BL, Qureshi ZP, Bandarenko N, Kwaan HC, Pandey DK, McKoy JM, Barnato SE, Winters JL, Cursio JF, Weiss I, "Ticlopidine-, clopidogrel-, and prasugrel-associated thrombotic thrombocytopenic purpura: a 20-year review from the Southern Network on Adverse Reactions (SONAR)", InSeminars in thrombosis and hemostasis, 2012 Jan .
- Frank P, "Ticlopidine-, Clopidogrel-, and Prasugrel-Associated Thrombotic Thrombocytopenic Purpura: A Twenty-Year Review from the Southern Network on Adverse Reactions (SONAR)", , 2012 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on clopidogrel (the active ingredients of Clopidogrel) and Clopidogrel (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Ambien cause Synovial Cyst? - a second ago
- Nefazodone Hydrochloride vs. Nardil, side effect and effectiveness comparison - 3 seconds ago
- Could Lexapro cause Foetal Exposure During Pregnancy? - 4 seconds ago
- Dry Eyes and drugs of ingredients of oxybutynin - 12 seconds ago
- Could Entyvio cause Drug Intolerance? - 15 seconds ago
- Could Fentanyl cause Therapeutic Response Decreased? - 16 seconds ago
- Proair Hfa and Hyperkalaemia for Men aged 50-59 - 18 seconds ago
- Proair Hfa and Blood Potassium Increased for Men aged 50-59 - 19 seconds ago
- Proair Hfa and Elevated Potassium for Men aged 50-59 - 19 seconds ago
- Proair Hfa and Potassium - High for Men aged 50-59 - 19 seconds ago